Figures & data
Figure 1. Medical outcome of modafinil and suvorexant exposures.
Table 1. Age, gender, and clinical outcomes of modafinil and suvorexant exposures.
Toxicology Communications
Volume 3, 2019 - Issue 1
Rapid Communications
Retrospective assessment of toxicity following exposure to Orexin pathway modulators modafinil and suvorexant
Jason L. RussellNationwide Children’s Hospital, Columbus, OH, USA; ;Central Ohio Poison Center, Columbus, OH, USA; ;The Ohio State University Wexner Medical Center, OH, USACorrespondence[email protected]
http://orcid.org/0000-0002-6709-1336
http://orcid.org/0000-0002-6709-1336 & Henry A. SpillerNationwide Children’s Hospital, Columbus, OH, USA; ;Central Ohio Poison Center, Columbus, OH, USA; http://orcid.org/0000-0002-0121-7055
http://orcid.org/0000-0002-0121-7055